Quick Answer
Semnur Pharmaceuticals, Inc. reported Total Assets of $1.35 million for fiscal year 2025.
Semnur Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.35M | -79.9% |
| 2024 | $6.68M | -86.8% |
| 2023 | $50.69M | -41.3% |
| 2022 | $86.28M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $774.0K | -91.3% | +37.6% |
| June 30, 2025 | $562.5K | -98.9% | -93.9% |
| March 31, 2025 | $9.15M | -82.2% | +36.9% |
| December 31, 2024 | $6.68M | -86.8% | -25.1% |
| September 30, 2024 | $8.92M | -90.1% | -82.9% |
| June 30, 2024 | $52.12M | -40.9% | +1.5% |
| March 31, 2024 | $51.35M | -41.0% | +1.3% |
| December 31, 2023 | $50.69M | -41.3% | -43.8% |
- Semnur Pharmaceuticals, Inc. showed a decrease of -79.9% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Semnur Pharmaceuticals, Inc.’s total assets has declined by 98.4% (from $86.28 million to $1.35 million).
- The most recent figure is from Semnur Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: